Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Gonococcal urethritis.

The Urologic Clinics of North America

|February 1, 1984

Summary

This summary is machine-generated.

Gonorrhea remains a common infectious disease. Increasing antibiotic resistance to penicillin, spectinomycin, and tetracycline complicates treatment choices for gonorrhea.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ceftriaxone in treatment of serious infections. Sexually transmitted diseases.

Hospital practice (Office ed.)·1991

Same author

HIV seroconversion with progressive disease in health care worker after needlestick injury.

Lancet (London, England)·1988

Same author

Treatment of gonorrhea with first- and second-generation cephalosporins and other new beta-lactam antibiotics.

Sexually transmitted diseases·1986

Same author

Cytotoxic lymphocytes generated in vivo with acute measles virus infection.

Clinical immunology and immunopathology·1985

Same author

A comparison of penicillin G plus a beta-lactamase inhibitor (sulbactam) with spectinomycin for treatment of urethritis caused by penicillinase-producing Neisseria gonorrhoeae.

Sexually transmitted diseases·1984

Same author

Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.

The New England journal of medicine·1984

Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026

Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026

Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026

Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026

Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026

Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026

See all related articles

Area of Science:

Infectious Diseases
Microbiology
Public Health

Background:

Gonorrhea is a leading reportable infectious disease in the U.S.
Penicillin is the standard treatment for uncomplicated gonococcal urethritis.
Rising penicillinase-producing Neisseria gonorrhoeae (PPNG) strains are a global concern.

Purpose of the Study:

To address the challenges posed by antibiotic resistance in Neisseria gonorrhoeae.
To evaluate the implications of increasing resistance on standard gonorrhea treatment protocols.

Main Methods:

Review of current treatment guidelines and resistance patterns.
Analysis of Neisseria gonorrhoeae resistance trends globally and in the U.S.
Assessment of alternative therapeutic options.

Related Experiment Videos

Main Results:

Penicillin resistance, particularly from PPNG, is increasing.
Resistance to spectinomycin and tetracycline is also complicating treatment.
Standard therapy requires reconsideration due to widespread resistance.

Conclusions:

The emergence of antibiotic-resistant Neisseria gonorrhoeae necessitates a re-evaluation of gonorrhea treatment strategies.
Alternative antibiotics and treatment approaches are crucial to combat resistant strains.
Continued surveillance of resistance patterns is essential for effective public health management.